EMBO Journal 2015-07-14

Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase.

Michal R Szymanski, Vladmir B Kuznetsov, Christie Shumate, Qingchao Meng, Young-Sam Lee, Gayatri Patel, Smita Patel, Y Whitney Yin

Index: EMBO J. 34 , 1959-70, (2015)

Full Text: HTML

Abstract

The human DNA polymerase gamma (Pol γ) is responsible for DNA replication in mitochondria. Pol γ is particularly susceptible to inhibition by dideoxynucleoside-based inhibitors designed to fight viral infection. Here, we report crystal structures of the replicating Pol γ-DNA complex bound to either substrate or zalcitabine, an inhibitor used for HIV reverse transcriptase. The structures reveal that zalcitabine binds to the Pol γ active site almost identically to the substrate dCTP, providing a structural basis for Pol γ-mediated drug toxicity. When compared to the apo form, Pol γ undergoes intra- and inter-subunit conformational changes upon formation of the ternary complex with primer/template DNA and substrate. We also find that the accessory subunit Pol γB, which lacks intrinsic enzymatic activity and does not contact the primer/template DNA directly, serves as an allosteric regulator of holoenzyme activities. The structures presented here suggest a mechanism for processivity of the holoenzyme and provide a model for understanding the deleterious effects of Pol γ mutations in human disease. Crystal structures of the mitochondrial DNA polymerase, Pol γ, in complex with substrate or antiviral inhibitor zalcitabine provide a basis for understanding Pol γ-mediated drug toxicity. © 2015 The Authors.

Related Compounds

Structure Name/CAS No. Articles
DL-CYSTEINE (1-13C) Structure DL-CYSTEINE (1-13C)
CAS:3374-22-9
2',3'-DIDEOXYCYTIDINE 5'-TRIPHOSPHATE SODIUM SALT Structure 2',3'-DIDEOXYCYTIDINE 5'-TRIPHOSPHATE SODIUM SALT
CAS:132619-66-0